1. Outcomes of Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency: A Report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry 
Richard Mitchell, Ian Nivison-Smith, Antoinette Anazodo, Karin Tiedemann, Peter Shaw, Lochie Teague, Chris Fraser, Tina Carter, Heather Tapp, Frank Alvaro, Tracey A. O’Brien 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 3, Pages (March 2013)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1 TRM in recipients of sibling and unrelated donor transplants.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
TRM in recipients of unrelated bone marrow and cord blood transplants.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 3
Five-year OS for the entire cohort was 72%, including 81% in patients with WAS, 70% in patients with SCID, 69% in patients with CGD, and 71% in patients with other immunodeficiencies.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

5. Figure 4
Five-year OS in recipients of sibling and unrelated donor transplants.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

6. Figure 5
Five-year OS in recipients of unrelated bone marrow and cord blood transplants.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions